This study is in progress, not accepting new patients
Saroglitazar Magnesium 4 Mg in the Treatment of NAFLD in Women with PCOS (EVIDENCES VII)
Summary
- Eligibility
- for females ages 18-45 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Zydus Therapeutics Inc.
- ID
- NCT03617263
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 60 people participating
- Last Updated